Ligand Pharmaceuticals | LGND - Cassa E Equivalenti





Cassa E Equivalenti Cambiamento Data
Agenus USD 18.74M 16.26M 2026-06
Amgen USD 13.99B 1.95B 2026-06
Anika Therapeutics USD 38.41M 2.61M 2026-06
Arrowhead Research USD 19.68M 127.85M 2026-06
Baxter International USD 2.15B 133M 2026-06
Bristol-Myers Squibb USD 8.72B 852M 2026-06
Eli Lilly USD 8.95B 3.67B 2026-06
Enanta Pharmaceuticals USD 37.44M 5.14M 2025-12
Enviri Corporation USD 105.7M 2.03M 2026-03
Gilead Sciences USD 7.63B 64M 2026-03
GlaxoSmithKline GBP 3.44B 292M 2026-03
Glaxosmithkline GBP 3.44B 146M 2026-03
Heron Therapeutics USD 20.72M 5.4M 2026-06
Insmed USD 544.76M 37.42M 2026-06
Intrexon USD 9.34M 1.77M 2024-06
Ionis Pharmaceuticals USD 350.06M 1.57B 2026-06
Karyopharm Therapeutics USD 90.85M 30.31M 2026-03
Ligand Pharmaceuticals USD 1.01B 891.62M 2026-06
MacroGenics USD 113.91M 47.39M 2026-06
Merck USD 6.85B 1.52B 2026-06
Pacira USD 205.88M 61.57M 2026-06
Pfizer USD 976M 727M 2026-06
Rigel Pharmaceuticals USD 48.53M 4.87M 2025-09
Sangamo BioSciences USD 38.34M 13.16M 2025-06
Veracyte USD 299.52M 36.38M 2026-06